| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | I4965C6W4O |
Structure
| InChI Key | FYXRSVDHGLUMHB-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C21H19F4N7 |
| Molecular Weight | 445.42 |
| AlogP | 4.3 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 75.52 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 32.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Ribosomal protein S6 kinase 1 inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
AGC protein kinase group
AGC protein kinase RSK family
AGC protein kinase p70 subfamily
|
- | 4 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Neuroendocrine Tumors | 1 | D018358 | ClinicalTrials |
| Neoplasm Metastasis | 1 | D009362 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3545076 |
| DrugBank | DB12690 |
| FDA SRS | I4965C6W4O |
| Guide to Pharmacology | 8248 |
| PubChem | 25118925 |
| SureChEMBL | SCHEMBL311369 |
| ZINC | ZINC000043204100 |
CONTENTS